215 related articles for article (PubMed ID: 16782755)
21. Prx1 controls vascular smooth muscle cell proliferation and tenascin-C expression and is upregulated with Prx2 in pulmonary vascular disease.
Jones FS; Meech R; Edelman DB; Oakey RJ; Jones PL
Circ Res; 2001 Jul; 89(2):131-8. PubMed ID: 11463719
[TBL] [Abstract][Full Text] [Related]
22. Serotonin induces Rho/ROCK-dependent activation of Smads 1/5/8 in pulmonary artery smooth muscle cells.
Liu Y; Ren W; Warburton R; Toksoz D; Fanburg BL
FASEB J; 2009 Jul; 23(7):2299-306. PubMed ID: 19244313
[TBL] [Abstract][Full Text] [Related]
23. Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension.
Wang L; Moonen JR; Cao A; Isobe S; Li CG; Tojais NF; Taylor S; Marciano DP; Chen PI; Gu M; Li D; Harper RL; El-Bizri N; Kim YM; Stankunas K; Rabinovitch M
Circ Res; 2023 Mar; 132(5):545-564. PubMed ID: 36744494
[TBL] [Abstract][Full Text] [Related]
24. Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells.
Yang J; Li X; Li Y; Southwood M; Ye L; Long L; Al-Lamki RS; Morrell NW
Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(4):L312-21. PubMed ID: 23771884
[TBL] [Abstract][Full Text] [Related]
25. Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle.
Hagen M; Fagan K; Steudel W; Carr M; Lane K; Rodman DM; West J
Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1473-9. PubMed ID: 17322283
[TBL] [Abstract][Full Text] [Related]
26. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
[TBL] [Abstract][Full Text] [Related]
27. Modulation of Endothelial Bone Morphogenetic Protein Receptor Type 2 Activity by Vascular Endothelial Growth Factor Receptor 3 in Pulmonary Arterial Hypertension.
Hwangbo C; Lee HW; Kang H; Ju H; Wiley DS; Papangeli I; Han J; Kim JD; Dunworth WP; Hu X; Lee S; El-Hely O; Sofer A; Pak B; Peterson L; Comhair S; Hwang EM; Park JY; Thomas JL; Bautch VL; Erzurum SC; Chun HJ; Jin SW
Circulation; 2017 Jun; 135(23):2288-2298. PubMed ID: 28356442
[TBL] [Abstract][Full Text] [Related]
28. Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8.
Drake KM; Zygmunt D; Mavrakis L; Harbor P; Wang L; Comhair SA; Erzurum SC; Aldred MA
Am J Respir Crit Care Med; 2011 Dec; 184(12):1400-8. PubMed ID: 21920918
[TBL] [Abstract][Full Text] [Related]
29. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
[TBL] [Abstract][Full Text] [Related]
30. Novel promoter and exon mutations of the BMPR2 gene in Chinese patients with pulmonary arterial hypertension.
Wang H; Li W; Zhang W; Sun K; Song X; Gao S; Zhang C; Hui R; Hu H
Eur J Hum Genet; 2009 Aug; 17(8):1063-9. PubMed ID: 19223935
[TBL] [Abstract][Full Text] [Related]
31. Deletion of the sequence encoding the tail domain of the bone morphogenetic protein type 2 receptor reveals a bone morphogenetic protein 7-specific gain of function.
Leyton PA; Beppu H; Pappas A; Martyn TM; Derwall M; Baron DM; Galdos R; Bloch DB; Bloch KD
PLoS One; 2013; 8(10):e76947. PubMed ID: 24116187
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension.
Takahashi H; Goto N; Kojima Y; Tsuda Y; Morio Y; Muramatsu M; Fukuchi Y
Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L450-8. PubMed ID: 16361357
[TBL] [Abstract][Full Text] [Related]
33. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
[TBL] [Abstract][Full Text] [Related]
34. BMP pathway regulation of and by macrophages.
Talati M; West J; Zaynagetdinov R; Hong CC; Han W; Blackwell T; Robinson L; Blackwell TS; Lane K
PLoS One; 2014; 9(4):e94119. PubMed ID: 24713633
[TBL] [Abstract][Full Text] [Related]
35. Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension.
Willers ED; Newman JH; Loyd JE; Robbins IM; Wheeler LA; Prince MA; Stanton KC; Cogan JA; Runo JR; Byrne D; Humbert M; Simonneau G; Sztrymf B; Morse JA; Knowles JA; Roberts KE; McElroy JJ; Barst RJ; Phillips JA
Am J Respir Crit Care Med; 2006 Apr; 173(7):798-802. PubMed ID: 16339917
[TBL] [Abstract][Full Text] [Related]
36. Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension.
Wong WK; Knowles JA; Morse JH
Am J Respir Cell Mol Biol; 2005 Nov; 33(5):438-46. PubMed ID: 16002577
[TBL] [Abstract][Full Text] [Related]
37. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
Orriols M; Gomez-Puerto MC; Ten Dijke P
Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
[TBL] [Abstract][Full Text] [Related]
38. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
39. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
[TBL] [Abstract][Full Text] [Related]
40. Molecular effects of loss of BMPR2 signaling in smooth muscle in a transgenic mouse model of PAH.
Tada Y; Majka S; Carr M; Harral J; Crona D; Kuriyama T; West J
Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1556-63. PubMed ID: 17369292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
